[1] Lee PJ, Mallik R. Cardiovascular effects of radiation therapy: Practical approach to radiation therapy-induced heart disease. Cardiol Rev, 2005, 13(2): 80-86.  doi: 10.1097/01.crd.0000131188.41589.c5
[2] Adams MJ, Lipshultz SE, Schwartz C, et al. Radiation-associated cardiovascular disease: manifestations and management. Semin Radiat Oncol, 2003, 13(3): 346-356.  doi: 10.1016/S1053-4296(03)00026-2
[3] Carver JR, Shapiro CL, Ng A, et al. American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol, 2007, 25(25): 3991-4008.  doi: 10.1200/JCO.2007.10.9777
[4] Heidenreich PA, Kapoor JR. Radiation induced heart disease: systemic disorders in heart disease. Heart, 2009, 95(3): 252-258.
[5] Veinot JP, Edwards WD. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol, 1996, 27(8): 766-773.  doi: 10.1016/S0046-8177(96)90447-5
[6] Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol, 1993, 11(7): 1208-1215.  doi: 10.1200/JCO.1993.11.7.1208
[7] Arsenian MA. Cardiovascular sequelae of therapeutic thoracic radiation. Prog Cardiovasc Dis, 1991, 33(5): 299-311.  doi: 10.1016/0033-0620(91)90022-E
[8] Lee CK, Aeppli D, Nierengarten ME. The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience. Int J Radiat Oncol Biol Phys, 2000, 48(1): 169-179.  doi: 10.1016/S0360-3016(00)00647-7
[9] Carlson RG, Mayfield WR, Normann S, et al. Radiation-associated valvular disease. Chest, 1991, 99(3): 538-545.  doi: 10.1378/chest.99.3.538
[10] Aleman BM, van den Belt-Dusebout AW, De Bruin ML, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood, 2007, 109(5): 1878-1886.  doi: 10.1182/blood-2006-07-034405
[11] Host H, Brennhovd IO, Loeb M. Postoperative radiotherapy in breast cancer long-term results from the Oslo study. Int J Radiat Oncol Biol Phys, 1986, 12(5): 727-732.  doi: 10.1016/0360-3016(86)90029-5
[12] Lauk S, Kiszel Z, Buschmann J, et al. Radiation-induced heart disease in rats. Int J Radiat Oncol Biol Phys, 1985, 11(4): 801-808.  doi: 10.1016/0360-3016(85)90314-1
[13] Carmel RJ, Kaplan HS. Mantle irradiation in Hodgkin's disease: An analysis of technique, tumor eradication, and complications. Cancer, 1976, 37(6): 2813-2825.  doi: 10.1002/1097-0142(197606)37:6<2813::AID-CNCR2820370637>3.0.CO;2-S
[14] Glanzmann C, Huguenin P, Lütolf UM, et al. Cardiac lesions after mediastinal radiation for Hodgkin's disease. Radiother Oncol, 1994, 30(1): 43-54.  doi: 10.1016/0167-8140(94)90008-6
[15] Schultz-Hector S, Trott KR. Radiation-induced cardiovascular disease: is the epidemiologic evidence compatible with radiobiologic data?. Int J Radiat Oncol Biol Phys, 2007, 67(1): 10-18.  doi: 10.1016/j.ijrobp.2006.08.071
[16] Swerdlow AJ, Higgins CD, Smith P, et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative british cohort study. J Natl Cancer Inst, 2007, 9(3): 206-214.
[17] Paszat LF, Mackillop WJ, Groome PA, et al. Mortality from myo-cardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol, 1998, 16(8): 2625-2631.  doi: 10.1200/JCO.1998.16.8.2625
[18] Hooning MJ, Botma A, Aleman BM, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst, 2007, 99(5): 365-375.  doi: 10.1093/jnci/djk064
[19] Pihkala J, Saarinen UM, Lundström U, et al. Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiation. Eur J Cancer, 1996, 32A(1): 97-103.
[20] Bovelli D, Plataniotis G, Roila F et al. Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines. Ann Oncol, 2010, 21 (Suppl5): v277-v282.
[21] Hull MC, Morris CG, Pepin CJ, et al. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. JAMA, 2003, 290(21): 2831-2837.  doi: 10.1001/jama.290.21.2831
[22] Boivin JF, Hutchison GB, Lubin JH, et al. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer, 1992, 69(5): 1241-1247.
[23] Giordano SH, Kuo YF, Freeman JL, et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst, 2005, 97(6): 419-424.  doi: 10.1093/jnci/dji067
[24] Lally BE, Detterbeck FC, Geiger AM, et al. The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: analysis of the Surveillance, Epidemiology, and End Results database. Cancer, 2007, 110(4): 911-917.  doi: 10.1002/cncr.22845
[25] Harris EE, Correa C, Hwang WT, et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. J Clin Oncol, 2006, 24(25): 4100-4106.  doi: 10.1200/JCO.2005.05.1037
[26]

Adams MJ, Hardenbergh PH, Constine LS, et al. Radiation-associated cardiovascular disease, 2003, 45(1): 55-75.
[27] Nellessen U, Zingel M, Hecker H, et al. Effects of radiation therapy on myocardial cell integrity and pump function: which role for cardiac biomarkers?. Chemotherapy, 2010, 56(2): 147-152.  doi: 10.1159/000313528
[28] Kozak KR, Hong TS, Sluss PM, et al. Cardiac blood biomarkers in patients receiving thoracic(chemo) radiation. Lung Cancer, 2008, 62(3): 351-355.  doi: 10.1016/j.lungcan.2008.03.024
[29] Hughes-Davies L, Sacks D, Rescigno J, et al. Serum cardiac troponin T levels during treatment of early-stage breast cancer. J Clin Oncol, 1995, 13(10): 2582-2584.  doi: 10.1200/JCO.1995.13.10.2582
[30] Stoodley PW, Richards DA, Meikle SR, et al. The potential role of echocardiographic strain imaging for evaluating cardiotoxicity due to cancer therapy. Heart Lung Circ, 2011, 20(1): 3-9.  doi: 10.1016/j.hlc.2010.09.007
[31] Gyenes G, Fornander T, Carlens P, et al. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective study. Int J Radiat Oncol Biol Phys, 1996, 36(4): 899-905.  doi: 10.1016/S0360-3016(96)00125-3
[32] Gayed IW, Liu HH, Yusuf SW, et al. The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer. J Nucl Med, 2006, 47(11): 1756-1762.
[33] Gayed IW, Liu HH, Yusuf SW, et al. Patterns of cardiac perfusion abnormalities after chemoradiotherapy in patients with lung cancer. J Thorac Oncol, 2009, 4(2): 179-184.  doi: 10.1097/JTO.0b013e3181990c46
[34] Yu X, Prosnitz RR, Zhou S, et al. Symptomatic cardiac events following radiation therapy for left sided breast cancer: possible association with radiation therapy-induced changes in regional perfusion. J Clin Breast Cancer, 2003, 4(3): 193-197.
[35] Yu X, Zhou S, Kahn D, et al. Persistence of radiation-induced cardiac perfusion defects 3-5 years post RT. J Clin Oncol, 2004, 22 (14 Suppl): 625.
[36] Marks LB, Yu X, Prosnitz RG, et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys, 2005, 63(1): 214-223.  doi: 10.1016/j.ijrobp.2005.01.029
[37] Jingu K, Kaneta T, Nemoto K, et al. The utility of 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage. Int J Radiat Oncol Biol Phys, 2006, 66(3): 845-851.  doi: 10.1016/j.ijrobp.2006.06.007
[38] Lee SM, Lee JJ, Kim YK, et al. Evaluation of radiation induced myocardial damage by FDG PET. J Nucl Med, 2010, 51(2S): 155.
[39] Darby SC, Cutter DJ, Boerma M, et al. Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys, 2010, 76(3): 656-665.  doi: 10.1016/j.ijrobp.2009.09.064
[40] Vallis KA, Pintilie M, Chong N, et al. Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer. J Clin Oncol, 2002, 20(4): 1036-1042.  doi: 10.1200/JCO.2002.20.4.1036
[41] Gagliardi G, Constine LS, Moiseenko V, et al. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys, 2010, 76(3 Suppl): S77-S85.
[42] Prosnitz RG, Marks LB. Radiation-induced heart disease: vigilance is still required. J Clin Oncol, 2005, 23(30): 7391-7394.  doi: 10.1200/JCO.2005.07.011
[43] Hendry JH, Akahoshi M, Wang LS, et al. Radiation-induced cardiovascular injury. Radiat Environ Biophys, 2008, 47(2): 189-193.  doi: 10.1007/s00411-007-0155-7